Glucose-dependent de novo lipogenesis in B lymphocytes: a requirement for atp-citrate lyase in lipopolysaccharide-induced differentiation.
Bacterially derived lipopolysaccharide (LPS) stimulates naive B lymphocytes to differentiate into immunoglobulin (Ig)-secreting plasma cells. Differentiation of B lymphocytes is characterized by a proliferative phase followed by expansion of the intracellular membrane secretory network to support Ig production. A key question in lymphocyte biology is how naive B cells reprogram metabolism to support de novo lipogenesis necessary for proliferation and expansion of the endomembrane network in response to LPS. We report that extracellularly acquired glucose is metabolized, in part, to support de novo lipogenesis in response to LPS stimulation of splenic B lymphocytes. LPS stimulation leads to increased levels of endogenous ATP-citrate lyase (ACLY), and this is accompanied by increased ACLY enzymatic activity. ACLY produces cytosolic acetyl-CoA from mitochondrially derived citrate. Inhibition of ACLY activity in LPS-stimulated B cells with the selective inhibitor 2-hydroxy-N-arylbenzenesulfonamide (compound-9; C-9) blocks glucose incorporation into de novo lipid biosynthesis, including cholesterol, free fatty acids, and neutral and acidic phospholipids. Moreover, inhibition of ACLY activity in splenic B cells results in inhibition of proliferation and defective endomembrane expansion and reduced expression of CD138 and Blimp-1, markers for plasma-like B cell differentiation. ACLY activity is also required for LPS-induced IgM production in CH12 B lymphoma cells. These data demonstrate that ACLY mediates glucose-dependent de novo lipogenesis in response to LPS signaling and identify a role for ACLY in several phenotypic changes that define plasma cell differentiation.
Department of Biology, Boston College, Chestnut Hill, Massachusetts 02467.
Fay J
FJ
Dufort
Department of Biology, Boston College, Chestnut Hill, Massachusetts 02467.
Maria R
MR
Gumina
Department of Biology, Boston College, Chestnut Hill, Massachusetts 02467.
Nathan L
NL
Ta
Sanford-Burnham Medical Research Institute La Jolla, California 92037.
Yongzhen
Y
Tao
Department of Biology, Boston College, Chestnut Hill, Massachusetts 02467.
Shannon A
SA
Heyse
Sanford-Burnham Medical Research Institute La Jolla, California 92037.
David A
DA
Scott
Sanford-Burnham Medical Research Institute La Jolla, California 92037.
Adam D
AD
Richardson
Department of Biology, Boston College, Chestnut Hill, Massachusetts 02467.
Thomas N
TN
Seyfried
Department of Biology, Boston College, Chestnut Hill, Massachusetts 02467. Electronic address: chilest@bc.edu.
Thomas C
TC
Chiles
D001275:ATP Citrate (pro-S)-Lyase / Q000037:antagonists & inhibitors / Q000502:physiology*; D000818:Animals; D001402:B-Lymphocytes / Q000166:cytology / Q000276:immunology*; D002454:Cell Differentiation; D005947:Glucose / Q000378:metabolism*; D050155:Lipogenesis / Q000276:immunology*; D008070:Lipopolysaccharides / Q000276:immunology*; D008213:Lymphocyte Activation; D051379:Mice; D008807:Mice, Inbred BALB C
D008070:Lipopolysaccharides; D001275:ATP Citrate (pro-S)-Lyase; D005947:Glucose
Acetyl Coenzyme A; Cell Metabolism; Differentiation; Glucose Metabolism; Lipogenesis; Lipopolysaccharide (LPS)